期刊文献+

治疗性疫苗的研究进展 被引量:3

Advance in Research on Therapeutic Vaccine
原文传递
导出
摘要 治疗性疫苗不仅具有预防性疫苗的间接靶向特异性和长效性等特点,而且还具有治疗性药物的疗效,尤其对一些目前尚无特效治疗药物的传染性疾病及肿瘤等可以起到治疗作用。近年来,治疗性疫苗的研究已取得了全面的进展。本文就治疗性疫苗的意义、作用机理及研究进展作一综述。 Therapeutic vaccine has not only the indirect targeting specificity and long-action of prophylactic vaccine,but also the curative effect of therapeutic drug,especially the curative effect on some infectious diseases without specifically effective drugs at present and tumors.In recent years,the research on therapeutic vaccine has made progress extensively.This paper reviews the significance,action mechanism and progress in research of therapeutic vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第4期486-490,共5页 Chinese Journal of Biologicals
关键词 治疗性疫苗 免疫治疗 慢性感染性疾病 肿瘤 Therapeutic vaccine Immune therapy Chronic infectious disease Tumor
  • 相关文献

参考文献3

二级参考文献36

  • 1Christian Rabe,Tillmann Pilz,Christoph Klostermann,Marc Berna,Hans H.Schild,Tilman Sauerbruch,Wolfgang H.Caselmann.Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(2):208-215. 被引量:60
  • 2Guo Hao Wu Yan Wei Zhang Zhao Han Wu Department of General Surgery.zhongshan Hospital,ShangHai Medical University.ShangHai 200032.China.Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients[J].World Journal of Gastroenterology,2001,7(3):357-362. 被引量:67
  • 3Hong-Chao Zhou De-Zhong Xu Xue-Ping Wang Jing-Xia Zhang Ying-Huang Yong-Ping Yan Yong Zhu Bo-Quan Jin Department of Epidemiology,the Fourth Military Medical University,Xi’an 710033,Shaanxi Province,ChinaDepartment of Immunology,the Fourth Military Medical University,Xi’an 710033,Shaanxi Province,China.Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes[J].World Journal of Gastroenterology,2001,7(4):583-586. 被引量:11
  • 4Senturk H;TabakF;Akdogan M.Therapeutic vaccination in chronic hepatitis B.[J],2002(01).
  • 5Emir S;BuyukpamukM;Akyuz C.The comparison of antibody response to different hepatitis bvaccines with and without pre-S2 antigen in children with cancer,2002(04).
  • 6Didici B;BosnakM;Ucmak H.Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B in fection[J],2003(02).
  • 7Page M;JonesCD;Bailey C.A novel, recombinant triple antigen hepatitis B vaccine[J],2001.
  • 8Zuckerman JN;ZuckermanAJ;Symington I.Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines[J],2001(04).
  • 9Jung MC;GrunerN;Zachoval R.Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers[J],2002(29-30).
  • 10Wen YM;QuD;Zhou SH.Antigen-antibody comples as therapeutic vaccine for viral hepatitis,1999(03).

共引文献17

同被引文献35

  • 1闻玉梅.治疗性疫苗的研究进展[J].中华微生物学和免疫学杂志,1996,16(3):155-158. 被引量:24
  • 2谢晓原,陈俊辉.肿瘤疫苗研究进展及应用现状[J].医学综述,2007,13(12):896-898. 被引量:2
  • 3Litjens NH, Huisman M, Baan CC, et al. Hepatitis B vaccine-spe- cific CD4+ T cells can be detected and characterised at the single cell level:limited usefulness of dendritic cells as signal enhancers [ J ]. J Immunol Methods ,2008,330 (1/2) : 1-11.
  • 4Gonzalez G, Crombet T, Lage A. Chronic vaccination with a thera- peutic EGF-based cancer vaccine: a review of patients receiving long lasting treatment [ J]. Curt Cancer Drug Targets, 2011,11 (1) :103-110.
  • 5Betting DJ, Mu XY, Kafi K, et al. Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect ceils involves mannose receptor targeting to antigen presenting cells [ J]. Vaccine,2009,27 (2) :250-259.
  • 6Kiessling A, Fussel S, Wehner R, et al. Advances in specific im- munotherapy for prostate cancer [ J ]. Eur Urol, 2008,53 ( 4 ) : 694-708.
  • 7Van Doomlaer K, Reimers LL, Studentsor YY, et al. Serological re- sponse to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia[ J ]. Gynecol Oncol, 2010,116 ( 2 ) : 208 -212.
  • 8Nemunaitis J, Jahan T, Ross H, et al. Phase 1 /2 trim of autologous tumormixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer[ J ]. Cancer Gene Ther, 2006,13 (6) : 555 -562.
  • 9Atanackovic D, Ahorki NK, Stockert E, et al. Vaccine-induced CD4 T cell responses to MAGE-3 protein in lung cancer patients [ J ]. J Immuno1,2004,172 (5) :3289-3296.
  • 10Inchausp6 G, Michel ML. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses [ J. J Viral Hepat,2007,14 ( 1 ) :97-103.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部